Parkman Healthcare Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
827,060
-127,011
| -13% | -$1.88M | 1.41% | 24 |
|
|
2025
Q1 | $17.1M | Sell |
954,071
-163,721
| -15% | -$2.93M | 2.03% | 15 |
|
|
2024
Q4 | $19.5M | Buy |
1,117,792
+31,725
| +3% | +$553K | 2.59% | 12 |
|
|
2024
Q3 | $15.2M | Buy |
1,086,067
+116,175
| +12% | +$1.63M | 1.94% | 16 |
|
|
2024
Q2 | $7.97M | Buy |
969,892
+1,472
| +0.2% | +$12.1K | 1.07% | 37 |
|
|
2024
Q1 | $7.47M | Sell |
968,420
-50,392
| -5% | -$389K | 0.92% | 40 |
|
|
2023
Q4 | $9.16M | Buy |
1,018,812
+441,318
| +76% | +$3.97M | 1.29% | 25 |
|
|
2023
Q3 | $5.16M | Buy |
577,494
+431,171
| +295% | +$3.85M | 0.95% | 35 |
|
|
2023
Q2 | $2.25M | Buy |
146,323
+4,436
| +3% | +$68.1K | 0.39% | 70 |
|
|
2023
Q1 | $3.19M | Buy |
141,887
+119,052
| +521% | +$2.68M | 0.69% | 46 |
|
|
2022
Q4 | $480K | Sell |
22,835
-3,730
| -14% | -$78.4K | 0.13% | 77 |
|
|
2022
Q3 | $655K | Buy |
26,565
+315
| +1% | +$7.77K | 0.19% | 81 |
|
|
2022
Q2 | $636K | Buy |
+26,250
| New | +$636K | 0.23% | 65 |
|